US Pediatric Cardiology Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US Pediatric Cardiology Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US Pediatric Cardiology Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US Pediatric Cardiology Market Country Analysis

6.2 US Pediatric Cardiology Market Revenue 2021-2031 (US$ Million)

6.3 US Pediatric Cardiology Market Forecast Analysis

7. US Pediatric Cardiology Market Analysis – by Product Type

7.1 Transcatheter Heart Valves

7.1.1 Overview
7.1.2 Transcatheter Heart Valves: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Occlusion Devices

7.2.1 Overview
7.2.2 Occlusion Devices: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Atherectomy Devices

7.3.1 Overview
7.3.2 Atherectomy Devices: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Catheters

7.4.1 Overview
7.4.2 Catheters: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Stents

7.5.1 Overview
7.5.2 Stents: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Introducer Sheaths

7.6.1 Overview
7.6.2 Introducer Sheaths: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. US Pediatric Cardiology Market Analysis – by Surgical Procedures

8.1 Interventional Procedures

8.1.1 Overview
8.1.2 Interventional Procedures: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Heart Rhythm Management Procedures

8.2.1 Overview
8.2.2 Heart Rhythm Management Procedures: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. US Pediatric Cardiology Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Specialty Clinics

9.2.1 Overview
9.2.2 Specialty Clinics: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. US Pediatric Cardiology Market Analysis – by Disease Indication

10.1 Patient Foramen Ovale

10.1.1 Overview
10.1.2 Patient Foramen Ovale: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Congenital Heart Disease

10.2.1 Overview
10.2.2 Congenital Heart Disease: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Acquired Heart Disease

10.3.1 Overview
10.3.2 Acquired Heart Disease: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Arrhythmias

10.4.1 Overview
10.4.2 Arrhythmias: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.5 Cardiomyopathies

10.5.1 Overview
10.5.2 Cardiomyopathies: US Pediatric Cardiology Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. US Pediatric Cardiology Market – United States Analysis

11.1 United States

11.1.1 United States: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.1 United States: US Pediatric Cardiology Market Breakdown, by Product Type
11.1.1.2 United States: US Pediatric Cardiology Market Breakdown, by Surgical Procedures
11.1.1.3 United States: US Pediatric Cardiology Market Breakdown, by End User
11.1.1.4 United States: US Pediatric Cardiology Market Breakdown, by Disease Indication

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Medtronic Plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Edwards Lifesciences Corp

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Terumo Corp

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 W L Gore & Associates Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 NuMED

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Cordis Corp

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Occlutech US LLC

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Biotronik SE & Co KG

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 RENATA MEDICAL

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

US Pediatric Cardiology Market